Correlation Between Kura Oncology and Madrigal Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Kura Oncology and Madrigal Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kura Oncology and Madrigal Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kura Oncology and Madrigal Pharmaceuticals, you can compare the effects of market volatilities on Kura Oncology and Madrigal Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kura Oncology with a short position of Madrigal Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kura Oncology and Madrigal Pharmaceuticals.
Diversification Opportunities for Kura Oncology and Madrigal Pharmaceuticals
-0.5 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Kura and Madrigal is -0.5. Overlapping area represents the amount of risk that can be diversified away by holding Kura Oncology and Madrigal Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Madrigal Pharmaceuticals and Kura Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kura Oncology are associated (or correlated) with Madrigal Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Madrigal Pharmaceuticals has no effect on the direction of Kura Oncology i.e., Kura Oncology and Madrigal Pharmaceuticals go up and down completely randomly.
Pair Corralation between Kura Oncology and Madrigal Pharmaceuticals
Given the investment horizon of 90 days Kura Oncology is expected to under-perform the Madrigal Pharmaceuticals. In addition to that, Kura Oncology is 1.2 times more volatile than Madrigal Pharmaceuticals. It trades about -0.2 of its total potential returns per unit of risk. Madrigal Pharmaceuticals is currently generating about 0.33 per unit of volatility. If you would invest 21,700 in Madrigal Pharmaceuticals on August 28, 2024 and sell it today you would earn a total of 12,818 from holding Madrigal Pharmaceuticals or generate 59.07% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Kura Oncology vs. Madrigal Pharmaceuticals
Performance |
| Timeline |
| Kura Oncology |
| Madrigal Pharmaceuticals |
Kura Oncology and Madrigal Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Kura Oncology and Madrigal Pharmaceuticals
The main advantage of trading using opposite Kura Oncology and Madrigal Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kura Oncology position performs unexpectedly, Madrigal Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Madrigal Pharmaceuticals will offset losses from the drop in Madrigal Pharmaceuticals' long position.| Kura Oncology vs. Eliem Therapeutics | Kura Oncology vs. Scpharmaceuticals | Kura Oncology vs. Milestone Pharmaceuticals | Kura Oncology vs. Seres Therapeutics |
| Madrigal Pharmaceuticals vs. Eliem Therapeutics | Madrigal Pharmaceuticals vs. Scpharmaceuticals | Madrigal Pharmaceuticals vs. Milestone Pharmaceuticals | Madrigal Pharmaceuticals vs. Seres Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Other Complementary Tools
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |